drugset / Trial / NCT00236444

A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders

NCT00236444

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of risperidone as maintenance therapy to prevent symptoms of relapse in children and adolescents with conduct and other disruptive behavior disorders, who initially responded well to treatment.

Timeline

Start
2001-12
Primary completion
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified 0.75 ml Oral
Subject Risperidone Other / unclassified 1.5 ml Oral